
- RIUMA Principal
- Listar por autor
Listar por autor "Arrabal-Gómez, José Carlos"
Mostrando ítems 1-3 de 3
-
Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats
Arrabal-Gómez, José Carlos; Rasiel, Beltran-Casanueva; Hernández-García, Aracelis; Bayolo-Guanche, Juan Vicente; Barbancho-Fernández, Miguel Ángel
; Serrano-Castro, Pedro Jesús
; Narváez, Manuel[et al.] (2024-04-12)
This study investigates the combined effects of the neuropeptide Y Y1 receptor (NPY1R) agonist [Leu31-Pro34]NPY at a dose of 132 g and Ketamine at 10 mg/Kg on cognitive functions and neuronal proliferation, against a ... -
Evidence for a synergistic effect of NPY1R agonist co-administered with Ketamine in rats: relevance to neurodegenerative and mood disorders.
Moreno Madrid, Isabel; Arrabal-Gómez, José Carlos; Díaz-Sánchez, Estela; Álvarez-Contino, José Erik; Barbancho-Fernández, Miguel Ángel
; Sánchez-Pérez, José Andrés; Blanco-Reina, Encarnación
; Beltrán-Casanueva, Rasiel; Hernández-García, Aracelis; Bayolo-Guanche, Juan Vicente; Romero-Imbroda, Jesús; Fuxe, Kjell; Borroto-Escuela, Dasiel O.; García-Casares, Natalia
; Serrano-Castro, Pedro; Narváez-Peláez, Manuel
[et al.] (2024)
Introduction/Objetives: Major depressive disorder is one of the most prevalent health problems worldwide and its current therapeutic approach still generates great dissatisfaction due to its limited efficacy, unwanted ... -
Synergistic Effects of Intranasally Administered GALR2 and Y1R Agonists on Cognitive and Mood-Related Behaviors in Adult Rats: Implications for Neurodegenerative and Mood Disorders
Moreno Madrid, Isabel; Arrabal-Gómez, José Carlos; Serrano-Castro, Pedro; Díaz-Sánchez, Estela; Álvarez-Contino, José Erik; Barbancho-Fernández, Miguel-Ángel; Sánchez-Pérez, José Andrés; Blanco-Reina, Encarnación
; Fuxe, Kjell; Borroto-Escuela, Dasiel O.; García-Casares, Natalia
; Narváez-Peláez, Manuel
[et al.] (2024-06)
Abstract body: Background: The complexity of neurodegenerative and mood disorders necessitates innovative therapeutic strategies beyond current treatments. This study explores the combined therapeutic potential of Galanin ...